Oppenheimer Upgrades Arch Chemicals (ARJ) to Outperform
More News related to ARJ
- Arch Chemicals (ARJ) Tops Q3 EPS by 11c; Issues Mixed Guidance for Q4 and FY09
- Arch Chemicals Reports Third Quarter 2009 Earnings and Narrows Its Full-Year 2009 Earnings Guidance
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- Arch Chemicals (ARJ) Declares $0.20 Dividend; 2.8% Yield
- Arch Chemicals, Inc. Declares Quarterly Dividend
More News related to Upgrades
- Morgan Stanley Upgrades CHU to Overweight, Downgrades CHL, CHA to Equal Weight
- Natixis Bleichroeder Downgrades Tenaris S.A. (TS) to Reduce
- Bank of America Downgrades Seneca Foods (SENEB) from Buy
- RBC Downgrades Intrepid Potash (IPI) to Sector Perform
- Lazard Capital Downgrades Abiomed (ABMD) to Hold
Oppenheimer upgrades Arch Chemicals (NYSE: ARJ) from Market Perform to Outperform. Price target $32.
Arch Chemicals, Inc. (Arch) is a global biocides company. The Company provides chemistry-based and related solutions to selectively destroy and control the growth of harmful microbes.
Related Categories
UpgradesStocks Mentioned
+0.78Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
